Literature DB >> 29212975

[Diffuse large B-cell lymphoma complicated with drug-induced vasculitis during administration of pegfilgrastim].

Yuta Ito1, Kentaro Noda2, Keisuke Aiba3, Shingo Yano3, Tsunehiro Fujii1.   

Abstract

A 59-year-old female with diffuse large B-cell lymphoma was treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone (R-CHOP) regimen. In addition, we administered pegfilgrastim for treating chemotherapy-induced febrile neutropenia. She complained of fever and neck and chest pain a few days after pegfilgrastim administration during the third and fourth courses of R-CHOP. Radiological imaging revealed an inflammation of large vessels, which led to the diagnosis of drug-associated vasculitis. We confirmed that vasculitis observed in this case was caused by pegfilgrastim administration because similar symptoms appeared with both injections of pegfilgrastim.

Entities:  

Keywords:  Diffuse large B-cell lymphoma; Drug-associated vasculitis; Pegfilgrastim

Mesh:

Substances:

Year:  2017        PMID: 29212975     DOI: 10.11406/rinketsu.58.2238

Source DB:  PubMed          Journal:  Rinsho Ketsueki        ISSN: 0485-1439


  3 in total

1.  Granulocyte colony-stimulating factor- and chemotherapy-induced large-vessel vasculitis: six patient cases and a systematic literature review.

Authors:  Kirsi Taimen; Samu Heino; Ia Kohonen; Heikki Relas; Riikka Huovinen; Arno Hänninen; Laura Pirilä
Journal:  Rheumatol Adv Pract       Date:  2020-02-06

2.  A Case of Cutaneous Leukocytoclastic Vasculitis Associated with Granulocyte Colony-Stimulating Factor: An Unusual Presentation.

Authors:  Dokyoung Yoon; Hyun Jeong Byun; Se Jin Oh; Ji-Hye Park; Dong-Youn Lee
Journal:  Ann Dermatol       Date:  2020-03-11       Impact factor: 1.444

3.  Granulocyte colony-stimulating factor associated arteritis in a patient with castration-resistant prostate cancer.

Authors:  Satoshi Nitta; Takazo Tanaka; Ryota Yanagihashi; Haruna Nonaka; Shuhei Suzuki; Tomokazu Kimura; Shuya Kandori; Akio Hoshi; Hiromitsu Negoro; Hiroyuki Nishiyama
Journal:  IJU Case Rep       Date:  2021-09-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.